COMMUNIQUÉ DE PRESSE
News
-
PPX Mining Announces Additional Convertible Debenture Conversion by Rivi Opportunity Fund
-
As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo
-
Datametrex Announces Enterprise Software Automation Contracts
-
Change Of Registered Address
-
NuRAN Wireless Files 40-F Registration Statement with SEC in Advance of U.S. Listing - A Major Step Toward Nasdaq
-
EQS-Adhoc: Siltronic AG: Siltronic AG launches cash capital increase from authorized share capital with exclusion of shareholders’ subscription rights through accelerated bookbuilding
-
Carvolix annonce des résultats cliniques positifs à 3 ans pour Kalios™, le seul anneau mitral ajustable. 100 % des patients atteignent le critère principal portant sur la régurgitation mitrale.
-
Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation.
-
LightOn accélère le passage à l’échelle de l’IA souveraine dans le secteur public.
-
Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.05.26